The big question
In mice with tumors, short-term fasting protected against the toxic effects of chemotherapy and helped it work better. Could a diet that mimics fasting do the same for people with breast cancer?
What they did
Researchers randomly assigned 131 people with HER2-negative stage II or III breast cancer, who were getting chemotherapy before surgery, to a fasting mimicking diet (FMD) or their usual diet. The FMD lasted 4 days around each chemo dose: plant-based soups, broths, liquids and tea, about 1,200 calories on day 1 and about 200 calories on days 2 to 4. The FMD group did not get dexamethasone, a steroid usually given to ease side effects.
What they found
Side effects were similar in both groups, even without the steroid. Tumors shrank on scans more often with the FMD: about 3 times the odds of a partial or complete response. Among people who stuck to the diet, near-total loss of tumor cells (90 to 100%) had about 4 times the odds. The diet also reduced chemo-related DNA damage in immune cells.
Why it matters
These results encourage more research on fasting-style diets as a partner to chemotherapy.
What it doesn't mean
This was a mid-sized phase 2 trial. Sticking to the diet was hard: 81.5% finished the first cycle and just over half finished two. A larger planned trial did not go ahead. One author reported an equity stake in L-Nutra. Do not fast during treatment without your care team.
Read the original abstract
Abstract reproduced from de Groot S et al., Nature Communications (2020), under a CC BY 4.0 license, with punctuation lightly adapted. Plain-English summary by Womanhattan.
This summary was written with AI assistance and checked against the original paper. It is for learning, not medical advice. Talk with your care team before changing anything about your health or treatment.